These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
589 related items for PubMed ID: 10445851
21. Regulation of JNK signaling by GSTp. Adler V, Yin Z, Fuchs SY, Benezra M, Rosario L, Tew KD, Pincus MR, Sardana M, Henderson CJ, Wolf CR, Davis RJ, Ronai Z. EMBO J; 1999 Mar 01; 18(5):1321-34. PubMed ID: 10064598 [Abstract] [Full Text] [Related]
22. Induction of cyclooxygenase-2 by the activated MEKK1 --> SEK1/MKK4 --> p38 mitogen-activated protein kinase pathway. Guan Z, Buckman SY, Pentland AP, Templeton DJ, Morrison AR. J Biol Chem; 1998 May 22; 273(21):12901-8. PubMed ID: 9582321 [Abstract] [Full Text] [Related]
23. TEL-JAK2 constitutively activates the extracellular signal-regulated kinase (ERK), stress-activated protein/Jun kinase (SAPK/JNK), and p38 signaling pathways. Ho JM, Nguyen MH, Dierov JK, Badger KM, Beattie BK, Tartaro P, Haq R, Zanke BW, Carroll MP, Barber DL. Blood; 2002 Aug 15; 100(4):1438-48. PubMed ID: 12149229 [Abstract] [Full Text] [Related]
24. Inhibition by dexamethasone of antigen-induced c-Jun N-terminal kinase activation in rat basophilic leukemia cells. Hirasawa N, Sato Y, Fujita Y, Mue S, Ohuchi K. J Immunol; 1998 Nov 01; 161(9):4939-43. PubMed ID: 9794429 [Abstract] [Full Text] [Related]
25. Activation of multiple proline-directed kinases by bacterial lipopolysaccharide in murine macrophages. Sanghera JS, Weinstein SL, Aluwalia M, Girn J, Pelech SL. J Immunol; 1996 Jun 01; 156(11):4457-65. PubMed ID: 8666821 [Abstract] [Full Text] [Related]
26. Involvement of extracellular signal-regulated kinase 2 and stress-activated protein kinase/Jun N-terminal kinase activation by transforming growth factor beta in the negative growth control of breast cancer cells. Frey RS, Mulder KM. Cancer Res; 1997 Feb 15; 57(4):628-33. PubMed ID: 9044838 [Abstract] [Full Text] [Related]
27. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K, Gotoh Y. Science; 1997 Jan 03; 275(5296):90-4. PubMed ID: 8974401 [Abstract] [Full Text] [Related]
28. Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia. Ferrer I, Friguls B, Dalfó E, Planas AM. Acta Neuropathol; 2003 May 03; 105(5):425-37. PubMed ID: 12677442 [Abstract] [Full Text] [Related]
29. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Coso OA, Chiariello M, Yu JC, Teramoto H, Crespo P, Xu N, Miki T, Gutkind JS. Cell; 1995 Jun 30; 81(7):1137-46. PubMed ID: 7600581 [Abstract] [Full Text] [Related]
30. R-Ras3, a brain-specific Ras-related protein, activates Akt and promotes cell survival in PC12 cells. Kimmelman AC, Osada M, Chan AM. Oncogene; 2000 Apr 13; 19(16):2014-22. PubMed ID: 10803462 [Abstract] [Full Text] [Related]
31. ets-2 is a target for an akt (Protein kinase B)/jun N-terminal kinase signaling pathway in macrophages of motheaten-viable mutant mice. Smith JL, Schaffner AE, Hofmeister JK, Hartman M, Wei G, Forsthoefel D, Hume DA, Ostrowski MC. Mol Cell Biol; 2000 Nov 13; 20(21):8026-34. PubMed ID: 11027273 [Abstract] [Full Text] [Related]
32. Differential regulation of mitogen-activated protein kinase kinase 4 (MKK4) and 7 (MKK7) by signaling from G protein beta gamma subunit in human embryonal kidney 293 cells. Yamauchi J, Kaziro Y, Itoh H. J Biol Chem; 1999 Jan 22; 274(4):1957-65. PubMed ID: 9890951 [Abstract] [Full Text] [Related]
33. Kit signaling through PI 3-kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation. Timokhina I, Kissel H, Stella G, Besmer P. EMBO J; 1998 Nov 02; 17(21):6250-62. PubMed ID: 9799234 [Abstract] [Full Text] [Related]
34. Signalling of the Ret receptor tyrosine kinase through the c-Jun NH2-terminal protein kinases (JNKS): evidence for a divergence of the ERKs and JNKs pathways induced by Ret. Chiariello M, Visconti R, Carlomagno F, Melillo RM, Bucci C, de Franciscis V, Fox GM, Jing S, Coso OA, Gutkind JS, Fusco A, Santoro M. Oncogene; 1998 May 14; 16(19):2435-45. PubMed ID: 9627110 [Abstract] [Full Text] [Related]
35. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav. Crespo P, Bustelo XR, Aaronson DS, Coso OA, Lopez-Barahona M, Barbacid M, Gutkind JS. Oncogene; 1996 Aug 01; 13(3):455-60. PubMed ID: 8760286 [Abstract] [Full Text] [Related]
36. Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity. Yang D, Tournier C, Wysk M, Lu HT, Xu J, Davis RJ, Flavell RA. Proc Natl Acad Sci U S A; 1997 Apr 01; 94(7):3004-9. PubMed ID: 9096336 [Abstract] [Full Text] [Related]
37. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor. Sutherland CL, Heath AW, Pelech SL, Young PR, Gold MR. J Immunol; 1996 Oct 15; 157(8):3381-90. PubMed ID: 8871635 [Abstract] [Full Text] [Related]
38. Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway. Bai RY, Ouyang T, Miething C, Morris SW, Peschel C, Duyster J. Blood; 2000 Dec 15; 96(13):4319-27. PubMed ID: 11110708 [Abstract] [Full Text] [Related]
39. Fc gamma receptor cross-linking activates p42, p38, and JNK/SAPK mitogen-activated protein kinases in murine macrophages: role for p42MAPK in Fc gamma receptor-stimulated TNF-alpha synthesis. Rose DM, Winston BW, Chan ED, Riches DW, Gerwins P, Johnson GL, Henson PM. J Immunol; 1997 Apr 01; 158(7):3433-8. PubMed ID: 9120304 [Abstract] [Full Text] [Related]
40. Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy. Choukroun G, Hajjar R, Kyriakis JM, Bonventre JV, Rosenzweig A, Force T. J Clin Invest; 1998 Oct 01; 102(7):1311-20. PubMed ID: 9769323 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]